2019

1. Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study

   Breast Cancer Research and Treatment, Vol. 174, Núm. 3, pp. 693-701